Atrás
37
Rango del Día
$20.10
$21.33
Rango de 52 Semanas
$19.94
$41.73
Volumen
839,025
Promedio 50D / 200D
$30.65
/
$31.45
Cierre Anterior
$20.45
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -17.6 | 0.4 |
| P/B | 0.6 | 2.9 |
| ROE % | -3.2 | 3.7 |
| Net Margin % | -9.4 | 3.9 |
| Rev Growth 5Y % | 3.7 | 10.0 |
| D/E | 0.1 | 0.2 |
Precio Objetivo de Analistas
Hold
$43.00
+101.8%
Low: $38.00
High: $45.00
P/E Futuro
26.0
EPS Futuro
$0.79
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
620 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$1.76
$1.73 – $1.80
|
740 M | 1 |
| FY2029 |
$1.30
$1.28 – $1.33
|
680 M | 1 |
| FY2028 |
$1.29
$1.05 – $1.47
|
700 M | 4 |
Puntos Clave
Revenue grew 3.69% annually over 5 years — modest growth
Debt/Equity of 0.06 — conservative balance sheet
Generating 38.32M in free cash flow
PEG of 0.39 suggests growth is underpriced
Capital efficient — spends only 5.70% of revenue on capex
Crecimiento
Revenue Growth (5Y)
3.69%
Revenue (1Y)3.55%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-3.19%
ROIC-0.46%
Net Margin-9.39%
Op. Margin-1.90%
Seguridad
Debt / Equity
0.06
Current Ratio2.98
Interest Coverage0.00
Valoración
P/E Ratio
-17.60
P/B Ratio0.57
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3.55% | Revenue Growth (3Y) | -5.51% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 3.69% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 593.82M | Net Income (TTM) | -55.76M |
| ROE | -3.19% | ROA | -2.71% |
| Gross Margin | 45.52% | Operating Margin | -1.90% |
| Net Margin | -9.39% | Free Cash Flow (TTM) | 38.32M |
| ROIC | -0.46% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.06 | Current Ratio | 2.98 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -17.60 | P/B Ratio | 0.57 |
| P/S Ratio | 1.65 | PEG Ratio | 0.39 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 981.57M | Enterprise Value | 812.96M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 593.82M | 573.45M | 665.07M | 555.50M | 513.70M |
| Net Income | -55.76M | -164.90M | -14.26M | -428.96M | 110.75M |
| EPS (Diluted) | -1.22 | -3.09 | -0.22 | -0.15 | -0.39 |
| Gross Profit | 270.28M | 254.62M | 233.26M | 230.62M | 214.51M |
| Operating Income | -11.27M | -29.98M | -82.20M | -24.02M | 3.60M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.06B | 2.10B | 2.89B | 3.72B | 1.82B |
| Total Liabilities | 330.70M | 331.07M | 351.22M | 352.74M | 494.18M |
| Shareholders' Equity | 1.73B | 1.77B | 2.53B | 3.36B | 1.33B |
| Total Debt | 111.17M | 70.68M | 60.44M | 49.23M | 94.77M |
| Cash & Equivalents | 279.78M | 310.93M | 678.91M | 658.27M | 227.43M |
| Current Assets | 708.34M | 832.81M | 1.42B | 2.46B | 777.37M |
| Current Liabilities | 237.67M | 204.84M | 210.93M | 230.55M | 345.09M |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#493 of 825
Actividad Reciente
Entró
Deep Value Investing (Seth Klarman)
Mar 24, 2026